OxySure Therapeutics, Inc.
company.status.inactiveCIK 1413797fmd_12JDMQAYWP71ZJ99RJNTW1V936Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2015, 22 periods
Latest annual · FY2014
Millions- Total revenues
- 2
- Gross profit
- 1
- Operating income
- (2)
- Net income
- (3)
- Free cash flow
- (1)
Latest quarter · Q3 FY2015
Millions- Total revenues
- 1
- Gross profit
- 1
- Operating income
- (1)
- Net income
- (1)
- Free cash flow
- (1)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2011 to FY2014
- n/m
OxySure Therapeutics, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2014 | FY2013 | Change | Source |
|---|---|---|---|---|
| Revenue | $2.4 million | $1.8 million | +35.4% | 10-K 2015-03-31 · proof |
| Gross profit | $1 million | $1.2 million | -15.7% | 10-K 2015-03-31 · proof |
| Operating income | -$2 million | -$488,298 | 10-K 2015-03-31 · proof | |
| Net income | -$2.8 million | -$712,452 | 10-K 2015-03-31 · proof | |
| Cash from operating activities | -$1.1 million | -$860,791 | 10-K 2015-03-31 · proof | |
| Free cash flow | -$1.2 million | -$872,896 | 10-K 2015-03-31 · proof | |
| Total assets | $2.5 million | $2.4 million | +6.8% | 10-K 2015-03-31 · proof |
| Total liabilities | $1.4 million | $928,980 | +54.6% | 10-K 2015-03-31 · proof |
| Cash and cash equivalents | $647,093 | $657,673 | -1.6% | 10-K 2015-03-31 · proof |
| Total debt | $44,484 | $180,626 | -75.4% | 10-K 2015-03-31 · proof |
- What was OxySure Therapeutics, Inc.'s revenue in fiscal 2014?
- OxySure Therapeutics, Inc. reported revenue of $2.4 million for fiscal 2014 (the year ended Dec 31, 2014), against $1.8 million the year before (+35.4%). Source: the 10-K filed with the SEC on Mar 31, 2015. SEC
- What was OxySure Therapeutics, Inc.'s gross profit in fiscal 2014?
- OxySure Therapeutics, Inc. reported gross profit of $1 million for fiscal 2014 (the year ended Dec 31, 2014), against $1.2 million the year before (-15.7%). Source: the 10-K filed with the SEC on Mar 31, 2015. SEC
- What was OxySure Therapeutics, Inc.'s operating income in fiscal 2014?
- OxySure Therapeutics, Inc. reported operating income of -$2 million for fiscal 2014 (the year ended Dec 31, 2014), against -$488,298 the year before. Source: the 10-K filed with the SEC on Mar 31, 2015. SEC
- What was OxySure Therapeutics, Inc.'s net income in fiscal 2014?
- OxySure Therapeutics, Inc. reported net income of -$2.8 million for fiscal 2014 (the year ended Dec 31, 2014), against -$712,452 the year before. Source: the 10-K filed with the SEC on Mar 31, 2015. SEC
- What was OxySure Therapeutics, Inc.'s cash from operating activities in fiscal 2014?
- OxySure Therapeutics, Inc. reported cash from operating activities of -$1.1 million for fiscal 2014 (the year ended Dec 31, 2014), against -$860,791 the year before. Source: the 10-K filed with the SEC on Mar 31, 2015. SEC
- What was OxySure Therapeutics, Inc.'s free cash flow in fiscal 2014?
- OxySure Therapeutics, Inc. reported free cash flow of -$1.2 million for fiscal 2014 (the year ended Dec 31, 2014), against -$872,896 the year before. Source: the 10-K filed with the SEC on Mar 31, 2015. SEC
- What are OxySure Therapeutics, Inc.'s total assets?
- As of Dec 31, 2014, OxySure Therapeutics, Inc. reported total assets of $2.5 million, against $2.4 million a year earlier (+6.8%). Source: the 10-K filed with the SEC on Mar 31, 2015. SEC
- What are OxySure Therapeutics, Inc.'s total liabilities?
- As of Dec 31, 2014, OxySure Therapeutics, Inc. reported total liabilities of $1.4 million, against $928,980 a year earlier (+54.6%). Source: the 10-K filed with the SEC on Mar 31, 2015. SEC
- What are OxySure Therapeutics, Inc.'s cash and cash equivalents?
- As of Dec 31, 2014, OxySure Therapeutics, Inc. reported cash and cash equivalents of $647,093, against $657,673 a year earlier (-1.6%). Source: the 10-K filed with the SEC on Mar 31, 2015. SEC
- What is OxySure Therapeutics, Inc.'s total debt?
- As of Dec 31, 2014, OxySure Therapeutics, Inc. reported total debt of $44,484, against $180,626 a year earlier (-75.4%). Source: the 10-K filed with the SEC on Mar 31, 2015. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1413797&period_type=annual&limit=5"Information only, not investment advice.